Reactivation of Trypanosoma cruzi Infection in the Central Nervous System after Solid Organ Transplant
Clinicians in the United States, public health workers, and healthcare students and trainees do not receive systematic training about Chagas disease, even though a large portion of the U.S. population is at risk, including immigrants from continental Latin America and people living in the Southern United States where the Triatomine vector is endemic. At-risk children, women of reproductive age, and immunocompromised individuals particularly should be screened for the disease, and those confirmed to be positive should be treated to reduce their risk of developing severe sequelae of Chagas disease. This case conference aims to advance learner knowledge about the evidence-based recommendations for Chagas disease diagnosis, management, monitoring of treatment side effects, and implementation of strategies for screening and prevention. The overall goals are to enhance the quality of care for patients with Chagas disease in the United States and to improve patient outcomes by reducing disease-related morbidity and mortality.
Physicians, medical students, fellows, and residents.
At the conclusion of the session, the participants should be able to:
Discuss the epidemiology and transmission of Chagas disease, its known risk factors, and its classical clinical manifestations.
Apply guideline-based strategies to screen for and diagnose Chagas disease.
Use public health tools to identify U.S. populations most at risk for Chagas disease and its sequelae.
Implement effective treatment regimens and recognize their common side effects.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation